ReviewOxidative medicine and cellular longevity2020

Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors.

Serge Camelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.